These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 985554)

  • 61. Isotopically labeled chlorobenzenes as probes for the mechanism of cytochrome P-450 catalyzed aromatic hydroxylation.
    Korzekwa KR; Swinney DC; Trager WF
    Biochemistry; 1989 Nov; 28(23):9019-27. PubMed ID: 2605239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Inhibition of bacterial luminescence by cytochrome P-450 substrates].
    Ismanlov AD; Baranova NA; Danilov VS; Egorov NS
    Biokhimiia; 1981 Feb; 46(2):234-9. PubMed ID: 7248381
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Glutathione as a scavenger of free hemin. A mechanism of preventing red cell membrane damage.
    Shviro Y; Shaklai N
    Biochem Pharmacol; 1987 Nov; 36(22):3801-7. PubMed ID: 3689422
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of replacement of ferriprotoporphyrin IX in the haem domain of cytochrome P-450 BM-3 on substrate binding and catalytic activity.
    Modi S; Primrose WU; Lian LY; Roberts GC
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):939-43. PubMed ID: 7575430
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum proteins as mediators of hemin efflux from red cell membranes: specificity of hemopexin.
    Solar I; Muller-Eberhard U; Shaklai N
    FEBS Lett; 1989 Oct; 256(1-2):225-9. PubMed ID: 2806549
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemical modification of microsomal cytochrome P450: role of lysyl residues in hydroxylation activity.
    Kunz BC; Richter C
    FEBS Lett; 1983 Sep; 161(2):311-4. PubMed ID: 6413255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glutathione-hemin complex as a cytochrome P-450 model characterization of the complex and its aromatic oxidation activities.
    Sakurai H; Shimomura S; Ishizu K
    Biochem Biophys Res Commun; 1981 Aug; 101(4):1102-8. PubMed ID: 6272772
    [No Abstract]   [Full Text] [Related]  

  • 68. Cleavage of DNA by model complexes of cytochrome P-450.
    Sakurai H; Shibuya M; Akimoto S; Maeda M; Kawasaki K
    Nucleic Acids Symp Ser; 1986; (17):159-62. PubMed ID: 3562262
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of the mutagenicity of amino acid pyrolysis products by hemin and other biological pyrrole pigments.
    Arimoto S; Ohara Y; Namba T; Negishi T; Hayatsu H
    Biochem Biophys Res Commun; 1980 Jan; 92(2):662-8. PubMed ID: 6986874
    [No Abstract]   [Full Text] [Related]  

  • 70. Oxygenated cytochrome P-450 as an intermediate in hydroxylation reactions.
    Estabrook RW; Baron J; Peterson J; Ishimura Y
    Biochem Soc Symp; 1972; 34():159-85. PubMed ID: 4348512
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of cytochrome b5 on cytochrome P-450-catalyzed reactions. Studies with manganese-substituted cytochrome b5.
    Morgan ET; Coon MJ
    Drug Metab Dispos; 1984; 12(3):358-64. PubMed ID: 6145564
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
    Locuson CW; Hutzler JM; Tracy TS
    Drug Metab Dispos; 2007 Apr; 35(4):614-22. PubMed ID: 17251307
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Reverse ferroporphyrin oxygenation in a bilayer phospholipid membrane].
    Vasilenko IA; Ushakova IP; Radiukhin VA; Filippovich EI; Serebrennikova GA
    Dokl Akad Nauk SSSR; 1978; 241(4):963-6. PubMed ID: 679811
    [No Abstract]   [Full Text] [Related]  

  • 74. Metal-metal interactions involving metalloporphyrins. III. Conversion of tetraphenylporphinatoiron(III) azide to an N-bridged hemin dimer.
    Summerville DA; Cohen IA
    J Am Chem Soc; 1976 Mar; 98(7):1747-52. PubMed ID: 3536
    [No Abstract]   [Full Text] [Related]  

  • 75. Esterification of hemins with trimethyloxonium tetrafluoroborate.
    Dean RT; DeFilippi LJ; Hultquist DE
    Anal Biochem; 1976 Nov; 76(l):1-8. PubMed ID: 998958
    [No Abstract]   [Full Text] [Related]  

  • 76. The quinine-haemin interaction and its relationship to antimalarial activity.
    Warhurst DC
    Biochem Pharmacol; 1981 Dec; 30(24):3323-7. PubMed ID: 7326041
    [No Abstract]   [Full Text] [Related]  

  • 77. Billiary excretion of exogenous hematin in rats.
    Petryka ZJ; Pierach CA; Smith A; Goertz MN; Edwards PS
    Life Sci; 1977 Oct; 21(7):1015-20. PubMed ID: 927017
    [No Abstract]   [Full Text] [Related]  

  • 78. Xylidine isomers. VII. Structure--hepatotoxic activity relationships of some xylidines.
    Weinberg J; Sahini VE
    J Theor Biol; 1981 Jan; 88(1):153-9. PubMed ID: 7266000
    [No Abstract]   [Full Text] [Related]  

  • 79. Letter: Oxygen binding to mercaptide-heme complexes. Models for reduced cytochrome P-450.
    Chang CK; Dolphin D
    J Am Chem Soc; 1976 Mar; 98(6):1607-9. PubMed ID: 1249373
    [No Abstract]   [Full Text] [Related]  

  • 80. Cellular hemins in diabetic patients.
    Pisanets M; Pavlov K
    Folia Med (Plovdiv); 1983; 25(2):29-32. PubMed ID: 6425128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.